Jabil (NYSE:JBL – Get Free Report) will likely be posting its Q2 2026 results before the market opens on Wednesday, March 18th. Analysts expect Jabil to post earnings of $2.56 per share and revenue of $7.7464 billion for the quarter. Jabil has set its FY 2026 guidance at 11.550-11.550 EPS and its Q2 2026 guidance […]

Eton Pharmaceuticals (NASDAQ:ETON – Get Free Report) is projected to release its Q4 2025 results after the market closes on Thursday, March 19th. Analysts expect Eton Pharmaceuticals to post earnings of $0.12 per share and revenue of $20.5790 million for the quarter. Investors may review the information on the company’s upcoming Q4 2025 earning report […]